Bengaluru, India

Nanjegowda Jagadeesh Mavinahalli



 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Nanjegowda Jagadeesh Mavinahalli: Innovator in Pharmaceutical Chemistry

Introduction

Nanjegowda Jagadeesh Mavinahalli is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of five patents to his name, Mavinahalli's work focuses on innovative solutions to complex medical challenges.

Latest Patents

Mavinahalli's latest patents include a series of substituted pyrazolo[1,5-a]pyridine compounds. These compounds are recognized for their potential as tropomyosin receptor kinase (Trk) inhibitors. The applications detail methods of making these compounds and their use in pharmaceutical compositions aimed at inhibiting the Trk family protein kinases. This research holds promise for advancing treatments in various medical conditions.

Career Highlights

Throughout his career, Mavinahalli has worked with notable organizations, including Dr. Reddy's Laboratories, where he has contributed to groundbreaking research and development projects. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Mavinahalli has collaborated with several professionals in his field, including Pradip Kumar Sasmal and Shahadat Ahmed. These partnerships have fostered innovation and have been instrumental in the advancement of his research initiatives.

Conclusion

Nanjegowda Jagadeesh Mavinahalli is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the field significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…